NM_033380.3(COL4A5):c.892-16del AND X-linked Alport syndrome
- Germline classification:
- Likely benign (1 submission)
- Last evaluated:
- Jul 22, 2021
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002496102.1
Allele description [Variation Report for NM_033380.3(COL4A5):c.892-16del]
NM_033380.3(COL4A5):c.892-16del
Condition(s)
-
Zea mays polygalacturonase inhibitor 2 (LOC100284303), mRNA
Zea mays polygalacturonase inhibitor 2 (LOC100284303), mRNAgi|1104469678|ref|NM_001157198.2|Nucleotide
-
Triplophysa bleekeri isolate F3202 myosin heavy polypeptide 6 gene, partial cds
Triplophysa bleekeri isolate F3202 myosin heavy polypeptide 6 gene, partial cdsgi|1567436180|gb|MG698529.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024